News & Updates

BP monitoring at home gathers most “likes” vs other methods

30 Oct 2021 by

People who need to check their blood pressure (BP) regularly to confirm if they have hypertension prefer BP monitoring done at home rather than at a clinic, kiosk, or through a 24-hour ambulatory BP monitoring (ABPM), suggest findings from the Blood Pressure Checks for Diagnosing Hypertension (BP-CHECK) trial presented at Hypertension 2021.

BP monitoring at home gathers most “likes” vs other methods

30 Oct 2021

Intraoperative dexamethasone may confer survival benefit in non-immunogenic cancers

30 Oct 2021 by

The intraoperative administration of dexamethasone in patients with non-immunogenic cancers may have survival benefits, according to a retrospective cohort study from the US presented at Anesthesiology 2021.

Intraoperative dexamethasone may confer survival benefit in non-immunogenic cancers

30 Oct 2021

What happens in women pregnant after COVID-19 vax?

29 Oct 2021 by

Vaccination with the ChAdOx1 nCoV-19 vaccine does not affect the rates of fertility, miscarriage, and other birth outcomes in women vaccinated before pregnancy, according to data from four ongoing clinical trials — adding to the body of evidence on the safety of COVID-19 vaccine in these women.

What happens in women pregnant after COVID-19 vax?

29 Oct 2021

Antidepressant useful in pain management following abdominal cancer surgery

29 Oct 2021

Administering a single dose of the serotonin and norepinephrine reuptake inhibitor (SNRI) duloxetine prior to a major abdominal cancer surgery leads to lower postoperative pain, reduced opioid requirement, and better quality of recovery, according to a study.

Antidepressant useful in pain management following abdominal cancer surgery

29 Oct 2021

Bamlanivimab + etesevimab combo reduces COVID-19-related hospitalization, any-cause death in high-risk patients

29 Oct 2021 by

The combination of bamlanivimab and etesevimab reduces the risk of COVID-19-related hospitalization and any-cause death in high-risk ambulatory patients, particularly those with diabetes, according to the BLAZE-1* study presented at EASD 2021.

Bamlanivimab + etesevimab combo reduces COVID-19-related hospitalization, any-cause death in high-risk patients

29 Oct 2021

Post-ICH antiplatelet therapy not linked to recurrent ICH

28 Oct 2021 by

Initiating antiplatelet therapy following an intracerebral haemorrhage (ICH) that occurred during antithrombotic use does not lead to recurrent symptomatic ICH, according to extended results of the RESTART* trial.

Post-ICH antiplatelet therapy not linked to recurrent ICH

28 Oct 2021

Iron pill: An answer to stave off heart disease?

28 Oct 2021 by

Having functional iron deficiency (FID) in mid-life puts one at higher risk of developing coronary heart disease (CHD) and death in later life, according to a large cohort study — indicating that these adverse events could have been avoided by preventing iron deficiency.

Iron pill: An answer to stave off heart disease?

28 Oct 2021

ULTIMATE: Biologic DMARD affords inflammation control in psoriatic arthritis

28 Oct 2021 by

Interleukin-17 inhibition with the biologic disease-modifying antirheumatic drug (DMARD) secukinumab appears to produce a substantial reduction in synovitis in psoriatic arthritis, in addition to improvements in the signs and symptoms of the disease, according to the results of the phase III ULTIMATE.

ULTIMATE: Biologic DMARD affords inflammation control in psoriatic arthritis

28 Oct 2021

Modified dual therapy on par with recommended regimen in H. pylori infection

28 Oct 2021

A modified dual therapy as first-line treatment for H. pylori infection demonstrates equal efficacy and compliance relative to recommended regimens, reveals a study. Moreover, a generally modified dual therapy has fewer side effects.

Modified dual therapy on par with recommended regimen in H. pylori infection

28 Oct 2021

FDA clears Moderna, J&J booster shots: Which one is right for you?

28 Oct 2021 by

The US Food and Drug Administration has given the green light to Moderna and Johnson & Johnson’s COVID-19 booster shots for eligible populations amid reports of waning immunity and breakthrough infections.

FDA clears Moderna, J&J booster shots: Which one is right for you?

28 Oct 2021

News & Updates

Filter by Specialty:

Specialty:

BP monitoring at home gathers most “likes” vs other methods

BP monitoring at home gathers most “likes” vs other methods

Intraoperative dexamethasone may confer survival benefit in non-immunogenic cancers

Intraoperative dexamethasone may confer survival benefit in non-immunogenic cancers

What happens in women pregnant after COVID-19 vax?

What happens in women pregnant after COVID-19 vax?

Antidepressant useful in pain management following abdominal cancer surgery

Antidepressant useful in pain management following abdominal cancer surgery

Bamlanivimab + etesevimab combo reduces COVID-19-related hospitalization, any-cause death in high-risk patients

Bamlanivimab + etesevimab combo reduces COVID-19-related hospitalization, any-cause death in high-risk patients

Post-ICH antiplatelet therapy not linked to recurrent ICH

Post-ICH antiplatelet therapy not linked to recurrent ICH

Iron pill: An answer to stave off heart disease?

Iron pill: An answer to stave off heart disease?

ULTIMATE: Biologic DMARD affords inflammation control in psoriatic arthritis

ULTIMATE: Biologic DMARD affords inflammation control in psoriatic arthritis

Modified dual therapy on par with recommended regimen in H. pylori infection

Modified dual therapy on par with recommended regimen in H. pylori infection

FDA clears Moderna, J&J booster shots: Which one is right for you?

FDA clears Moderna, J&J booster shots: Which one is right for you?